Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cullinan Metals Corp V.CMT


Primary Symbol: C.CMT Alternate Symbol(s):  CMTNF

Cullinan Metals Corp. is a Canadian mining and exploration company focused on the development of energy metals. The Company is focused on energy resources, such as copper, graphite and lithium assets. Its projects include Smiley Lithium Project, Lac-Des-Iles West Graphite Project and Wakeman Lake Lithium Project. The Smiley Lithium Property consists of around five mining claims comprising approximately 1,902 hectares located 55 kilometers (km) north of Thunder Bay, Ontario. The Smiley Lake Lithium property is located in northwestern Ontario where numerous lithium deposits have been delineated to host significant reserves of lithium oxide (Li2O). The Lac-Des-Iles West Graphite Project consists of around 43 mineral claims in one contiguous block covering approximately 2276 hectares land, near the town of Mont-Laurier in southern Quebec. The highly prospective Wakeman Lake Lithium Project covers approximately 7,900 acres and is located in Northwestern Ontario.


CSE:CMT - Post by User

Post by BirchBrookon Nov 08, 2019 7:04am
79 Views
Post# 30325901

THC OVERDOSE ANTIDOTE patent pending " True Focus"

THC OVERDOSE ANTIDOTE patent pending " True Focus"

THC OVERDOSE ANTIDOTE

In conjunction with the Company’s edibles educational campaign, AgraFlora will also market and distribute its patent-pending THC overdose antidote, True Focus into the company's 17,500 North American points of distribution. Delivered to the end-consumer through a pocket-sized, user-friendly spray bottle, True Focus's revolutionary formulations are to be ingested in a sublingual (under the tongue) manner.

True Focus boasts nutraceutical formulations, coupled with an intuitive delivery system designed to mitigate the negative side effects associated with excessive THC consumption. The aforementioned product formulations are considered patent pending by way of a U.S. Patent and Trademark Office (USPTO) patent application.

Recreational cannabis consumption, for the purpose of achieving desired levels of euphoric or psychoactive effects can, at times, lead to adverse and unwanted side effects, given the lack of consistent dose distinction or historical use. True Focus's patent-pending formulation offers a unique solution to alleviating undesirable symptoms associated with a THC overdose. AgraFlora holds the exclusive Canadian True Focus sublicense, which permits the domestic marketing, distribution and development of True Focus's product suite and proprietary intellectual property portfolio.

About AgraFlora Organics International Inc.

<< Previous
Bullboard Posts
Next >>